title: Clinical importance of human herpes virus-8 and human immunodeficiency virus infection in primary effusion lymphoma.
abstract: Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma that usually develops in immunosuppressed patients infected with human herpes virus-8 (HHV-8) in conjunction with human immunodeficiency virus (HIV) infection. However, there are several reports of HHV-8-related HIV-negative cases and HHV-8-unrelated HIV-negative cases, mainly in immunodeficient and elderly patients. Here, we report one case of HHV-8-related HIV-negative PEL with gastric cancer (case 1) and one case of HHV-8-unrelated HIV-negative effusion-based lymphoma (case 2), both in elderly men. A 73-year-old man and a 79-year-old man were admitted because of lymphomatous effusions, and no mass was detectable in both cases. They were diagnosed as having malignant effusion lymphoma on the basis of cytological findings indicating atypical lymphoid cells and the expression of CD20 and CD79a. To detect evidence of HHV-8 infection in neoplastic cells, immunocytochemical staining for ORF73/ latent nuclear antigen-1 (LNA-1) was performed. The results revealed that case 1 was ORF73-positive, and case 2 was ORF73-negative. Rituximab-based chemotherapy (R-THPCOP: rituximab, pirarubicin, cyclophosphamide, vincristine, prednisolone) was administered to both patients and complete remission was achieved in both. Compared to most HIV-positive PEL cases, these two cases showed a good response to chemotherapy. In cases of PEL, we should focus on HHV-8 infection and HIV status for determining prognosis.
authors.affiliation: Department of Hematology, National Hospital Organization, Osaka Minami Medical Center, Osaka, Japan.
authors.forename: Takahiro
authors.initials: T
authors.lastname: Kumode
authors.forename: Yasuyo
authors.initials: Y
authors.lastname: Ohyama
authors.forename: Masaya
authors.initials: M
authors.lastname: Kawauchi
authors.forename: Terufumi
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: Jun-ichi
authors.initials: J
authors.lastname: Miyatake
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Hoshida
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Tatsumi
authors.forename: Itaru
authors.initials: I
authors.lastname: Matsumura
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Maeda
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018450:Disease Progression; D006678:HIV; D015658:HIV Infections / Q000150:complications*; D006566:Herpesviridae Infections / Q000150:complications*; D019288:Herpesvirus 8, Human; D006801:Humans; D016130:Immunophenotyping; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology; D054685:Lymphoma, Primary Effusion / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D016066:Pleural Effusion, Malignant / Q000175:diagnosis / Q000209:etiology; D011859:Radiography; D016896:Treatment Outcome